ZimVie (NASDAQ:ZIMV) Coverage Initiated by Analysts at JPMorgan Chase & Co.

JPMorgan Chase & Co. assumed coverage on shares of ZimVie (NASDAQ:ZIMVGet Rating) in a research note issued to investors on Friday, The Fly reports. The firm issued a neutral rating on the stock.

A number of other research analysts have also issued reports on ZIMV. Credit Suisse Group started coverage on ZimVie in a report on Tuesday, March 1st. They issued an underperform rating and a $34.00 target price for the company. Guggenheim began coverage on ZimVie in a research note on Friday, March 18th. They issued a neutral rating on the stock.

NASDAQ:ZIMV opened at $18.08 on Friday. The company has a fifty day moving average of $22.91. ZimVie has a 12-month low of $17.53 and a 12-month high of $50.40. The company has a quick ratio of 1.41, a current ratio of 2.50 and a debt-to-equity ratio of 0.72.

In other ZimVie news, insider Vafa Jamali purchased 10,000 shares of the business’s stock in a transaction on Tuesday, May 10th. The shares were bought at an average cost of $20.04 per share, for a total transaction of $200,400.00. Following the completion of the purchase, the insider now directly owns 100,030 shares in the company, valued at $2,004,601.20. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

About ZimVie (Get Rating)

ZimVie Inc, a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies.

Featured Articles

The Fly logo

Want More Great Investing Ideas?

Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.